European Urology Oncology National Practice Patterns and Overall Survival After Adjuvant Radiotherapy Following Radical Cystectomy for Urothelial Bladder Cancer in the USA, 2004–2013  Zhoobin H. Bateni, Shane M. Pearce, Daniel Zainfeld, Leslie Ballas, Hooman Djaladat, Anne K. Schuckman, Siamak Daneshmand  European Urology Oncology  DOI: 10.1016/j.euo.2018.11.010 Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 1 Mean rates of adjuvant radiation therapy use after radical cystectomy for urothelial bladder cancer in different geographical regions in the USA from 2003 to 2014. European Urology Oncology DOI: (10.1016/j.euo.2018.11.010) Copyright © 2018 European Association of Urology Terms and Conditions

Fig. 2 Kaplan-Meier OS curves for the ART and no-ART groups with (A) pT2 disease, (B) pT3 disease, (C) pT4 disease, and (D) positive surgical margins. OS=overall survival; ART=adjuvant radiation therapy; HR=hazard ratio. European Urology Oncology DOI: (10.1016/j.euo.2018.11.010) Copyright © 2018 European Association of Urology Terms and Conditions